首頁 › 肝癌（肝細胞癌） › 明尼蘇達 › Rochester
Rochester, MN 的 肝癌（肝細胞癌） 臨床試驗
12 項針對 肝癌（肝細胞癌） 的研究正在 Rochester（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
招募中1/2 期
- Mayo Clinic in Rochester, Rochester
A Phase 1 Study of the Safety and Tolerability of CTX-10726
招募中1 期
- Mayo Clinic Rochester, Rochester
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #68, Rochester
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
招募中1/2 期
- Research Facility, Rochester
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
招募中3 期
- Research Site, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Mayo Clinic, Rochester
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
招募中2 期
- Mayo Clinic in Rochester, Rochester
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
招募中觀察性研究
- Mayo Clinic, Rochester
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
招募中1 期
- Clinical Trial Site, Rochester
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
招募中觀察性研究
- Mayo Clinic in Rochester, Rochester
The Dragon PLC Trial (DRAGON-PLC)
招募中
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Mayo Clinic in Minnesota, Rochester
其他城市的 肝癌（肝細胞癌） 試驗
- Houston, TX31 項研究
- New York City, NY24 項研究
- Dallas, TX19 項研究
- Los Angeles, CA19 項研究
- Boston, MA18 項研究
- Cleveland, OH18 項研究
- Chicago, IL16 項研究
- Philadelphia, PA16 項研究
- Pittsburgh, PA15 項研究
- San Francisco, CA14 項研究
- Orange, CA14 項研究
- Jacksonville, FL14 項研究
Rochester 的其他研究
- 乳癌42 項研究
- 非小細胞肺癌37 項研究
- 轉移性癌症31 項研究
- 癌症（所有類型）30 項研究
- 卵巢癌29 項研究
- 大腸直腸癌29 項研究
- 多發性骨髓瘤24 項研究
- 心臟衰竭22 項研究
- 前列腺癌22 項研究
- 胰臟癌22 項研究
- 子宮內膜癌20 項研究
- 肺癌20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。